Regulation of Inflammation- and Infection-Driven Hematopoiesis

Trends in Immunology

Volumn 38, Issue 5, 2017, Pages 345-357

  Boettcher, Steffen ^a   Manz, Markus G ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE;

CYTOKINE PRODUCTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; COMPLICATION; HEMATOLOGIC DISEASE; IMMUNOLOGY; NEUTROPHIL;

ANIMALS; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; INFECTION; INFLAMMATION; MODELS, IMMUNOLOGICAL; NEUTROPHILS; SIGNAL TRANSDUCTION;

EID: 85012929561     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2017.01.004     Document Type: Review

References (102)

1. 1 Kondo, M., et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21 (2003), 759–806.
2. 2 Dancey, J.T., et al. Neutrophil kinetics in man. J. Clin. Invest. 58 (1976), 705–715.
3. 3 Takizawa, H., et al. Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood 119 (2012), 2991–3002.
4. 4 Manz, M.G., Boettcher, S., Emergency granulopoiesis. Nat. Rev. Immunol. 14 (2014), 302–314.
5. 5 Zhao, J.L., Baltimore, D., Regulation of stress-induced hematopoiesis. Curr. Opin. Hematol. 22 (2015), 286–292.
6. 6 Boettcher, S., Manz, M.G., Sensing and translation of pathogen signals into demand-adapted myelopoiesis. Curr. Opin. Hematol. 23 (2016), 5–10.
7. 7 Iwasaki, A., Medzhitov, R., Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004), 987–995.
8. 8 Kawai, T., Akira, S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11 (2010), 373–384.
9. 9 Nagai, Y., et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24 (2006), 801–812.
10. 10 Schmid, M.A., et al. Bone marrow dendritic cell progenitors sense pathogens via Toll-like receptors and subsequently migrate to inflamed lymph nodes. Blood 118 (2011), 4829–4840.
11. 11 De Luca, K., et al. The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate. Leukemia 23 (2009), 2063–2074.
12. + progenitor cells along the myeloid lineage. J. Mol. Biol. 364 (2006), 945–954.
13. 13 Chicha, L., et al. Clonal type I interferon-producing and dendritic cell precursors are contained in both human lymphoid and myeloid progenitor populations. J. Exp. Med. 200 (2004), 1519–1524.
14. 14 Wright, D.E., et al. Physiological migration of hematopoietic stem and progenitor cells. Science 294 (2001), 1933–1936.
15. 15 Massberg, S., et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 131 (2007), 994–1008.
16. + plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat. Immunol. 8 (2007), 1207–1216.
17. 17 Liu, A., et al. Cutting edge: hematopoietic stem cell expansion and common lymphoid progenitor depletion require hematopoietic-derived, cell-autonomous TLR4 in a model of chronic endotoxin. J. Immunol. 195 (2015), 2524–2528.
18. 18 Zhao, J.L., et al. Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis. Cell Stem Cell 14 (2014), 445–459.
19. 19 Buechler, M.B., et al. Cutting edge: direct sensing of TLR7 ligands and type I IFN by the common myeloid progenitor promotes mTOR/PI3K-dependent emergency myelopoiesis. J. Immunol. 197 (2016), 2577–2582.
20. 20 Hamilton, J.A., Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8 (2008), 533–544.
21. 21 Kaushansky, K., Lineage-specific hematopoietic growth factors. N. Engl. J. Med. 354 (2006), 2034–2045.
22. 22 He, R.L., et al. Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 113 (2009), 429–437.
23. 23 Vellenga, E., et al. Independent regulation of M-CSF and G-CSF gene expression in human monocytes. Blood 71 (1988), 1529–1532.
24. 24 de Waal Malefyt, R., Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174 (1991), 1209–1220.
25. 25 Nishizawa, M., Nagata, S., Regulatory elements responsible for inducible expression of the granulocyte colony-stimulating factor gene in macrophages. Mol. Cell. Biol. 10 (1990), 2002–2011.
26. 26 Boettcher, S., et al. Cutting edge: LPS-induced emergency myelopoiesis depends on TLR4-expressing nonhematopoietic cells. J. Immunol. 188 (2012), 5824–5828.
27. 27 Schilling, J.D., et al. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 4203–4208.
28. 28 Hammad, H., et al. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat. Med. 15 (2009), 410–416.
29. 29 Andonegui, G., et al. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J. Clin. Invest. 111 (2003), 1011–1020.
30. 30 Andonegui, G., et al. Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic gram-negative bacterial infection. J. Clin. Invest. 119 (2009), 1921–1930.
31. 31 Hwa Cho, H., et al. Role of Toll-like receptors on human adipose-derived stromal cells. Stem Cells 24 (2006), 2744–2752.
32. 32 Liotta, F., et al. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells 26 (2008), 279–289.
33. 33 Tomchuck, S.L., et al. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 26 (2008), 99–107.
34. 34 Pevsner-Fischer, M., Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109 (2007), 1422–1432.
35. 35 Shi, C., et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating Toll-like receptor ligands. Immunity 34 (2011), 590–601.
36. 36 Boettcher, S., et al. Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis. Blood 124 (2014), 1393–1403.
37. 37 Lieschke, G.J., et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84 (1994), 1737–1746.
38. 38 Liu, F., et al. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5 (1996), 491–501.
39. 39 Zhan, Y., et al. Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice. Blood 91 (1998), 863–869.
40. 40 Basu, S., et al. “Emergency” granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Blood 95 (2000), 3725–3733.
41. 41 Wilson, A., et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135 (2008), 1118–1129.
42. 42 Saito, Y., et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat. Biotechnol. 28 (2010), 275–280.
43. 43 Kovtonyuk, L.V., et al. Enhanced thrombopoietin but not G-CSF receptor stimulation induces self-renewing hematopoietic stem cell divisions in vivo. Blood 127 (2016), 3175–3179.
44. 44 Gasson, J.C., Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77 (1991), 1131–1145.
45. 45 Lang, R.A., et al. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 51 (1987), 675–686.
46. 46 Metcalf, D., et al. Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp. Hematol. 15 (1987), 1–9.
47. 47 Stanley, E., et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 5592–5596.
48. 48 Seymour, J.F., et al. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood 90 (1997), 3037–3049.
49. 49 Kingston, D., et al. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 114 (2009), 835–843.
50. 50 Zhan, Y., Cheers, C., Haemopoiesis in mice genetically lacking granulocyte-macrophage colony stimulating factor during chronic infection with Mycobacterium avium. Immunol. Cell Biol. 78 (2000), 118–123.
51. 51 Hibbs, M.L., et al. Mice lacking three myeloid colony-stimulating factors (G-CSF, GM-CSF, and M-CSF) still produce macrophages and granulocytes and mount an inflammatory response in a sterile model of peritonitis. J. Immunol. 178 (2007), 6435–6443.
52. 52 Rieger, M.A., et al. Hematopoietic cytokines can instruct lineage choice. Science 325 (2009), 217–218.
53. 53 Mossadegh-Keller, N., M-CSF instructs myeloid lineage fate in single haematopoietic stem cells. Nature 497 (2013), 239–243.
54. 54 Panopoulos, A.D., et al. STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 108 (2006), 3682–3690.
55. 55 Kopf, M., et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368 (1994), 339–342.
56. 56 Bernad, A., et al. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1 (1994), 725–731.
57. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183 (1996), 1345–1355.
58. 58 Walker, F., et al. IL6/sIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice. Blood 111 (2008), 3978–3985.
59. + T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. Cell Stem Cell 14 (2014), 460–472.
60. 60 Sugiyama, T., et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25 (2006), 977–988.
61. 61 Dinarello, C.A., Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27 (2009), 519–550.
62. 62 Eisenbarth, S.C., et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453 (2008), 1122–1126.
63. 63 Ueda, Y., et al. IL-1R type I-dependent hemopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia. J. Immunol. 182 (2009), 6477–6484.
64. 64 Pietras, E.M., et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat. Cell Biol. 18 (2016), 607–618.
65. 65 Glaccum, M.B., et al. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159 (1997), 3364–3371.
66. 66 Yang, Y.C., et al. Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 47 (1986), 3–10.
67. 67 Weber, G.F., et al. Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. Science 347 (2015), 1260–1265.
68. 68 Rauch, P.J., et al. Innate response activator B cells protect against microbial sepsis. Science 335 (2012), 597–601.
69. 69 Essers, M.A.G., et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458 (2009), 904–908.
70. 70 Baldridge, M.T., et al. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 465 (2010), 793–797.
71. 71 Sato, T., et al. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat. Med. 15 (2009), 696–700.
72. 72 de Bruin, A.M., et al. Interferon-γ impairs proliferation of hematopoietic stem cells in mice. Blood 121 (2013), 3578–3585.
73. 73 de Bruin, A.M., et al. IFNγ induces monopoiesis and inhibits neutrophil development during inflammation. Blood 119 (2012), 1543–1554.
74. 74 Pietras, E.M., et al. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J. Exp. Med. 211 (2014), 245–262.
75. 75 Ito, K., et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431 (2004), 997–1002.
76. 76 Ito, K., et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 12 (2006), 446–451.
77. 77 Jang, Y.-Y., Sharkis, S.J., A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 110 (2007), 3056–3063.
78. 78 Lewandowski, D., et al. In vivo cellular imaging pinpoints the role of reactive oxygen species in the early steps of adult hematopoietic reconstitution. Blood 115 (2010), 443–452.
79. 79 Kwak, H.-J., et al. Myeloid cell-derived reactive oxygen species externally regulate the proliferation of myeloid progenitors in emergency granulopoiesis. Immunity 42 (2015), 159–171.
80. 80 Takizawa, H., et al. Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J. Exp. Med. 208 (2011), 273–284.
81. 81 Esplin, B.L., et al. Chronic exposure to a TLR ligand injures hematopoietic stem cells. J. Immunol. 186 (2011), 5367–5375.
82. 82 Maeda, K., et al. Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. Blood 113 (2009), 4534–4540.
83. 83 Terashima, A., et al. Sepsis-induced osteoblast ablation causes immunodeficiency. Immunity 44 (2016), 1434–1443.
84. 84 Ueda, Y., et al. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J. Exp. Med. 201 (2005), 1771–1780.
85. 85 Ueda, Y., et al. Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J. Exp. Med. 199 (2004), 47–58.
86. 86 Yang, C., et al. The physiological response of thrombopoietin (c-Mpl ligand) to thrombocytopenia in the rat. Br. J. Haematol. 105 (1999), 478–485.
87. 87 Stoffel, R., et al. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 87 (1996), 567–573.
88. 88 Saito, Y., et al. Dendritic cell homeostasis is maintained by nonhematopoietic and T-cell-produced Flt3-ligand in steady state and during immune responses. Eur. J. Immunol. 43 (2013), 1651–1658.
89. 89 Cain, D.W., et al. Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism. PLoS One, 6, 2011, e19957.
90. 90 Bugl, S., et al. Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling. Blood 121 (2013), 723–733.
91. 91 Kristinsson, S.Y., Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 95 (2010), 1216–1220.
92. 92 Kristinsson, S.Y., Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J. Clin. Oncol. 29 (2011), 2897–2903.
93. 93 Pasqualucci, L., et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat. Genet. 43 (2011), 830–837.
94. 94 Puente, X.S., et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475 (2011), 101–105.
95. 95 Ngo, V.N., et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 470 (2011), 115–119.
96. 96 Treon, S.P., et al. MYD88 L265P somatic mutation in Waldenström's Macroglobulinemia. N. Engl. J. Med. 367 (2012), 826–833.
97. 97 Bharadwaj, U., et al. Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res. 67 (2007), 5479–5488.
98. 98 Cohen, P.R., et al. Sweet syndrome in patients with solid tumors. Cancer 72 (1993), 2723–2731.
99. 99 Gabrilovich, D.I., Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9 (2009), 162–174.
100. 100 Waight, J.D., et al. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS One, 6, 2011 e27690–e27615.
101. 101 Abrams, S.I., Waight, J.D., Identification of a G-CSF-granulocytic MDSC axis that promotes tumor progression. Oncoimmunology 1 (2014), 550–551.
102. 102 Strauss, L., et al. RORC1 regulates tumor-promoting “emergency” granulo-monocytopoiesis. Cancer Cell 28 (2015), 253–269.